<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03234517</url>
  </required_header>
  <id_info>
    <org_study_id>zuh- 8</org_study_id>
    <nct_id>NCT03234517</nct_id>
  </id_info>
  <brief_title>Vaginal Clindamycin Cream Plus Vaginal Probiotic for Bacterial Vaginosis</brief_title>
  <official_title>Vaginal Clindamycin Cream Plus Vaginal Probiotic for Bacterial Vaginosis Continuous Versus Interrupted Use. a Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zagazig University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zagazig University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vaginal Clindamycin Cream Plus Vaginal probiotic for treatment of Bacterial Vaginosis
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vaginal Clindamycin Cream was used initially for treatment of Bacterial Vaginosis followed by
      Vaginal probiotic either in cnotinous or interrupted manner, then assessment of the results
      of treatment at different time intervals was done.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>initial cure rate</measure>
    <time_frame>2 months</time_frame>
    <description>number of women completely cured</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>recurrence rate</measure>
    <time_frame>4,6,8and12 months</time_frame>
    <description>number of women had recurrence</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Bacterial Vaginosis Treatment</condition>
  <arm_group>
    <arm_group_label>Vaginal Clindamycin Cream Plus continuous Vaginal Probiotic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vaginal Clindamycin Cream followed by continuous Vaginal Probiotic use for 60 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vaginal Clindamycin Cream Plus interrupted Vaginal Probiotic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vaginal Clindamycin Cream followed by interrupted Vaginal Probiotic use</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vaginal Clindamycin Cream</intervention_name>
    <description>Vaginal Clindamycin Cream</description>
    <arm_group_label>Vaginal Clindamycin Cream Plus continuous Vaginal Probiotic</arm_group_label>
    <arm_group_label>Vaginal Clindamycin Cream Plus interrupted Vaginal Probiotic</arm_group_label>
    <other_name>dalacin c cream</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vaginal Probiotic</intervention_name>
    <description>Vaginal Probiotic</description>
    <arm_group_label>Vaginal Clindamycin Cream Plus continuous Vaginal Probiotic</arm_group_label>
    <arm_group_label>Vaginal Clindamycin Cream Plus interrupted Vaginal Probiotic</arm_group_label>
    <other_name>dicoflor vaginal capsules</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  more than 18 years

          -  has recurrent Bacterial Vaginosis

        Exclusion Criteria:

          -  pregnancy

          -  use of other antmicrobial

          -  not provide informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ibrahim A EL sharkwy</last_name>
    <role>Principal Investigator</role>
    <affiliation>FACULTY OF MEDICINE ,ZAGAZIG UNIVERSITY</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ibrahim A EL sharkwy</last_name>
    <phone>00966554818576</phone>
    <email>ibrahimsharkwy@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mohamed L Elsayed</last_name>
    <phone>00201222442467</phone>
    <email>drmohamedlotfy@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zagazig University</name>
      <address>
        <city>Zagazig</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 26, 2017</study_first_submitted>
  <study_first_submitted_qc>July 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 31, 2017</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zagazig University</investigator_affiliation>
    <investigator_full_name>IBRAHIM ABD ELGAFOR</investigator_full_name>
    <investigator_title>assistant professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaginal Diseases</mesh_term>
    <mesh_term>Vaginosis, Bacterial</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clindamycin</mesh_term>
    <mesh_term>Clindamycin palmitate</mesh_term>
    <mesh_term>Clindamycin phosphate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

